Skip to main content

Implantable Defibrillator User

0
Pipeline Programs
6
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Boston Scientific
Boston ScientificCA - Valencia
2 programs
Implantable Cardioverter DefibrillatorN/A
Implantable Cardioverter Defibrillator implantN/A1 trial
Active Trials
NCT05938283Completed5Est. Jan 2026
Biotronik
BiotronikGermany - Berlin
2 programs
Plexa ICD Lead RegistryN/A1 trial
Protego DF4 Post Approval RegistryN/A1 trial
Active Trials
NCT03103503Terminated901Est. Sep 2019
NCT02243696Terminated1,694Est. Apr 2019
Abbott
AbbottABBOTT PARK, IL
1 program
Ellipse VR ICD and Durata/Optisure leadN/A1 trial
Active Trials
NCT02787291Completed227Est. Apr 2018
Medtronic
MedtronicNJ - Phillipsburg
1 program
Implantable Cardioverter DefibrillatorN/A1 trial
Active Trials
NCT02491853Completed1,545Est. Jun 2016
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
Implantable cardioverter-defibrillatorsN/A1 trial
Active Trials
NCT05116176Enrolling By Invitation500Est. Mar 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Boston ScientificImplantable Cardioverter Defibrillator implant
Colorado TherapeuticsImplantable cardioverter-defibrillators
BiotronikPlexa ICD Lead Registry
AbbottEllipse VR ICD and Durata/Optisure lead
BiotronikProtego DF4 Post Approval Registry
MedtronicImplantable Cardioverter Defibrillator

Clinical Trials (6)

Total enrollment: 4,872 patients across 6 trials

NCT05938283Boston ScientificImplantable Cardioverter Defibrillator implant

Pilot Study of Hypertrophic Cardiomyopathy & Implantable Cardioverter Defibrillator Assessment: (Subcutaneous vs Transvenous)

Start: Jan 2024Est. completion: Jan 20265 patients
N/ACompleted
NCT05116176Colorado TherapeuticsImplantable cardioverter-defibrillators

TRAjectories and CLinical ExpeRiences of ICD Therapy Study

Start: Dec 2021Est. completion: Mar 2026500 patients
N/AEnrolling By Invitation
NCT03103503BiotronikPlexa ICD Lead Registry

Plexa ICD Lead Registry

Start: May 2017Est. completion: Sep 2019901 patients
N/ATerminated
NCT02787291AbbottEllipse VR ICD and Durata/Optisure lead

A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse VR ICD Undergoing MRI, an IDE Study

Start: May 2016Est. completion: Apr 2018227 patients
N/ACompleted
NCT02243696BiotronikProtego DF4 Post Approval Registry

Protego DF4 Post Approval Registry

Start: Sep 2014Est. completion: Apr 20191,694 patients
N/ATerminated
NCT02491853MedtronicImplantable Cardioverter Defibrillator

The Gulf Implantable Cardioverter-Defibrillator Registry

Start: Jan 2014Est. completion: Jun 20161,545 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.